NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BioGenerator Ventures

BioGenerator Ventures

Saint Louis, Michiganbiogeneratorventures.com

Overview

BioGenerator Ventures is a venture capital firm and the investment arm of BioSTL that creates, builds, and invests in early-stage companies solving problems in human health and agriculture. The firm invests in the therapeutics, diagnostics, medical devices, research tools, and agtech sectors.

Year Founded

2003

Portfolio Companies

42

Investments

BioGenerator Ventures investments
CompanyDateStageLead
Allotera TherapeuticsJul 2026Series C ExtensionCo-investor
WugenJul 2026Series C ExtensionCo-investor
SalunaJun 2026Seed RoundCo-investor
SentiARMay 2026SeedLead
Agrela EcosystemsMar 2026SeedCo-investor

Key People

Allyson Mayer

Principal

Ann Guggisberg

Principal

Mark Lewis

Venture Capital Fellow

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersSaint Louis, Michigan
Year Founded2003

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.